Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-20-047615

President & CEO sold 11,885 shares at $19.67 ($233,778)

From the SEC's structured data for this filing

Trades in this filing

ROBIN HOWARD W · President & CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2020-08-17 Sale : show line 1 in the form −11,885 $19.67 $233,778 364,018 D
Open-market sales · 11,885 sh · avg $19.67 · $233,778
Loading xslF345X03/doc4.xml…